Hematologically important mutations: Spectrin and ankyrin variants in hereditary spherocytosis

Blood Cells, Molecules, and Diseases

Volumn 24, Issue 4, 1998, Pages 539-543

  Gallagher, Patrick G ^a   Forget, Bernard G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; ERYTHROCYTE BAND 3 PROTEIN; ERYTHROCYTE BAND 4.2 PROTEIN; FODRIN; PROTEIN SUBUNIT; SPECTRIN;

DELETION MUTANT; DISEASE CLASSIFICATION; ERYTHROCYTE MEMBRANE; FRAMESHIFT MUTATION; GENE INSERTION; GENE MUTATION; HEREDITARY SPHEROCYTOSIS; HUMAN; MISSENSE MUTATION; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEFECT; REVIEW;

EID: 0032451030     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.1998.0217     Document Type: Article

References (48)

1. 1. Backer P, Lux S. Disorders of the red cell membrane skeleton: Hereditary spherocytosis and hereditary elliptocytosis. In: Scriver C, Beaudet A, Sly W, et al., eds. The Metabolic Basis of Inherited Disease. New York: McGraw-Hill. pp. 529-632, 1995.
2. 2. Gallagher PG, Ferriera JD. Molecular basis of erythrocyte membrane disorders. Curr Opin Hematol 4:128-135, 1997.
3. 3. Hassoun H, Palek J. Hereditary spherocytosis: a review of the clinical and molecular aspects of the disease. Blood Rev 10:129-147, 1996.
4. 4. Delaunay J. Genetic disorders of the red cell membranes. FEBS Lett 369:34-37, 1995.
5. 5. Lux SE, Palek J. Disorders of the red cell membrane. In: Handin RI, Lux SE, Stossel TP, eds. Blood: Principles and Practice of Hematology. Philadelphia: JB Lippincott. pp. 1701-1816, 1995.
6. 6. Palek J, Jarolim P. Clinical expression and laboratory detection of red blood cell membrane protein mutations. Semin Hematol 30:249-283, 1993.
7. 7. Agre P, Orringer EP, Bennett V. Deficient red-cell spectrin in severe, recessively inherited spherocytosis. N Engl J Med 306:1155-1161, 1982.
8. 8. Agre P, Casella JF, Zinkham WH, McMillan C, Bennett V. Partial deficiency of erythrocyte spectrin in hereditary spherocytosis. Nature 314:380-383, 1985.
9. 9. Coetzer TL, Lawler J, Liu SC, et al. Partial ankyrin and spectrin deficiency in severe, atypical hereditary spherocytosis. N Engl J Med 318:230-234, 1988.
10. 10. Hanspal M, Yoon S, Yu H, et al. Molecular basis of spectrin and ankyrin deficiencies in severe hereditary spherocytosis: Evidence implicating a primary defect of ankyrin. Blood 77:165-173, 1991.
11. 11. Whitfield CF, Follweiler JB, Lopresti-Morrow L, Miller BA. Deficiency of α-spectrin synthesis in burst-forming units-erythroid in lethal hereditay spherocytosis. Blood 78:3043-3051, 1991.
12. 12. Savvides P, Shalev O, John KM, Lux SE. Combined spectrin and ankyrin deficiency is common in autosomal dominant hereditary spherocytosis. Blood 82:2953-2960, 1993.
13. 13. Saad ST, Costa FF, Vicentim DL, Salles TS, Pranke, P. H. Red cell membrane protein abnormalities in hereditary spherocytosis in Brazil. Br J Haematol 88:295-299, 1994.
14. 14. Gallagher PG, Forget BG: Hematologically important mutations: Band 3 and protein 4.2 variants in hereditary spherocytosis. Blood Cells Mol Dis 23:417-421, 1997.
15. 15. Gallagher PG, Forget BG. Spectrin genes in health and disease. Semin Hematol 30:4-20, 1993.
16. 16. Winkelmann JC, Forget BG. Erythroid and nonerythroid spectrins. Blood 81:3173-3185, 1993.
17. 17. Delaunay J, Dhermy D. Mutations involving the spectrin heterodimer contact site: Clinical expression and alterations in specific functions. Semin Hematol 30:21-33, 1993.
18. 18. Hanspal M, Palek J. Synthesis and assembly of membrane skeletal proteins in mammalian red cell precursors. J Cell Biol 105:1417-1424, 1987.
19. 19. Hanspal M, Palek J. Biogenesis of normal and abnormal red blood cell membrane skeleton. Semin Hematol 29:305-319, 1992.
20. 20. Lux SE, Tse WT, Menninger JC, et al. Hereditary spherocytosis associated with deletion of human erythrocyte ankyrin gene on chromosome 8. Nature 345:736-739, 1990.
21. 21. Costa FF, Agre P, Watkins PC, et al. Linkage of dominant hereditary spherocytosis to the gene for the erythrocyte membrane skeleton protein ankyrin. N Engl J Med 323:1046-1050, 1990.
22. 22. Jarolim P, Rubin HL, Brabec V, Palek J: Comparison of the ankyrin (AC) microsatellites in genomic DNA and mRNA reveals absence of one ankyrin mRNA allele in 20% of patients with hereditary spherocytosis. Blood 85:3278-3282, 1995.
23. 23. Sahr KE, Laurila P, Kotula L, et al. The complete cDNA and polypeptide sequence of human erythroid α spectrin. J Biol Chem 265:4434-4443, 1990.
24. 24. Winkelmann JC, Chang JC, Tse WT, Scarpa AL, Marchesi VT, Forget BG. Full length sequence of the cDNA for human erythroid β spectrin. J Biol Chem 265:11827-11832, 1990.
25. 25. Beutler E, McKusick VA, Motulsky AG, Scriver CR, Hutchinson F. Mutation nomenclature: nicknames, systematic names, and unique identifiers. Hum Mutation 8:203-206, 1996
26. 26. Lux SE, John KM, Bennett V Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins. Nature 344:36-42, 1990.
27. 27. Wichterle H, Hanspal M, Palek J, Jarolim P. Combination of two mutant α spectrin alleles underlies a severe spherocytic hemolytic anemia. J Clin Invest 98:2300-2307, 1996.
28. 28. Basseres DS, Vicentim DL, Costa FF, Saad STO, Hassoun H. beta-spectrin Promissao: A translation initiation codon mutation of the beta-spectrin gene (ATG-GTG) associated with hereditary spherocytosis and spectrin deficiency in a Brazilian family. Blood 91:368-369, 1998.
29. 29. Garbarz M, Galand C, Bibas D, et al. A 5' splice region G-C mutation in exon 3 of the human beta-spectrin gene leads to decreased levels of β spectrin mRNA and is responsible for dominant hereditary spherocytosis (spectrin Guemene-Penfao). Br J Haematol 100:90-98, 1998.
30. 30. Hassoun H, Vassiliadis JN, Murray J, et al. Characterization of the underlying molecular defect in hereditary spherocytosis associated with spectrin deficiency. Blood 90:398-406, 1997.
31. 31. Dhermy D, Galand C, Bournier O, Cynober T, et al. Hereditary spherocytosis with spectrin deficiency related to mull mutations of the β-spectrin gene. Blood Cells Mol Dis 24:251-261, 1998
32. 32. Becker PS, Tse WT, Lux SE, Forget BG. β spectrin Kissimmee - a spectrin variant associated with autosomal dominant hereditary spherocytosis and defective binding to protein 4.1. J Clin Invest 92:612-616, 1993.
33. 33. Basseres DS, Tavares AC, Bordin S, et al. Novel β-spectrin variants associated with hereditary spherocytosis. Blood 90(Suppl 1):4b(Abstract), 1997
34. 34. Hassoun H, Vassiliadis JN, Murray J, et al. Hereditary spherocytosis with spectrin deficiency due to an unstable truncated beta spectrin. Blood 87:2538-2545, 1996.
35. 35. Hassoun H, Vassiliadis JN, Murray J, et al. Molecular basis of spectrin deficiency in β spectrin Durham - A deletion within β spectrin adjacent to the ankyrin-binding site precludes spectrin attachment to the membrane in hereditary spherocytosis. J Clin Invest 96:2623-2629, 1995.
36. 36. Eber SW, Gonzalez JM, Lux ML, et al. Ankyrin-1 mutations are a major cause of dominant and recessive hereditary spherocytosis. Nat Genet 13:214-218, 1996.
37. 37. Basseres DS, Bordin S, Costa FF, Gallagher PG, Saad STO. A novel ankyrin promoter mutation associated with hereditary spherocytosis. Blood 92(Suppl 1):8a (Abstract), 1998.
38. 38. Morle L, Bozon M, Alloisio N, et al. Ankyrin Bugey: A de novo deletional frameshift variant in exon 6 of the ankyrin gene associated with spherocytosis. Am J Hematol 54:242-248, 1997.
39. 39. Randon J, Miraglia del Giudice EM, Bozon M, et al. Frequent de novo mutations of the ANK1 gene mimic a recessive mode of transmission in hereditary spherocytosis: Three new ANK1 variants: Ankyrins Bari, Napoli II and Anzio. Br J Haematol 96:500-506, 1997.
40. 40. Gallagher PG, Ferreira JDS, Saad STO, Kerbally J, Costa FF, Forget B. A recurring frameshift mutation of the ankyrin-1 gene in associated with severe hereditary spherocytosis in Brazil. Blood 88(Suppl 1):6a(Abstract), 1996.
41. 41. Miraglia del Giudice EM, Hayette S, Bozon M, et al. Ankyrin Napoli: a de novo deletional frameshift mutation in exon 16 of ankyrin gene (ANK1) associated with spherocytosis. Br J Haematol 93:828-834, 1996.
42. 42. Ozcan R, Kugler W, Feuring-Buske M, Schroter W, Lux SE, Eber SW. Parental mosaicism for ankyrin-1 mutations in two families with hereditary spherocytosis. Blood 90(Suppl):4a( Abstract), 1997.
43. 43. Ozcan R, Jarolim P, Brabec V, Lux SE, Eber SW. High frequency of frameshift/nonsense mutations of ankyrin-1 in Czech patients with dominant hereditary spherocytosis (DHS). Blood 88(Suppl 1):5a(Abstract), 1996.
44. 44. Kanzaki A, Takezono M, Kaku M, et al. Molecular and genetic characteristics in Japanese patients with hereditary spherocytosis: Frequent band 3 mutations and rarer ankyrin mutations. Blood 90(Suppl 1):6b(Abstract), 1997.
45. 45. Jarolim P, Brabec V, Lambert S, Liu SC, Zhou Z, Palek J. Ankyrin Prague: a dominantly inherited mutation of the regulatory domain of ankyrin associated with hereditary spherocytosis. Blood 76(Suppl):37a(Abstract), 1990.
46. Rakovnik) Blood 82(Suppl):5a(Abstract), 1993.
47. 47. Hayette S, Carre G, Bozon M, et al. Two distinct truncated variants of ankyrin associated with hereditary spherocytosis. Am J Hematol 58:36-41, 1998.
48. 48. Jarolim P, Rubin HL, Brabec V, Palek J. A nonsense mutation 1669Glu-Ter within the regulatory domain of human erythroid ankyrin leads to a selective deficiency of the major ankyrin isoform (band 2.1) and a phenotype of autosomal dominant hereditary spherocytosis. J Clin Invest 94:941-947, 1995.